201 related articles for article (PubMed ID: 9719128)
1. Response of quiescent and total tumor cells in solid tumors to neutrons with various cadmium ratios.
Masunaga S; Ono K; Sakurai Y; Takagaki M; Kobayashi T; Suzuki M; Kinashi Y; Akaboshi M
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1163-70. PubMed ID: 9719128
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors.
Masunaga S; Ono K; Sakurai Y; Takagaki M; Kobayashi T; Kinashi Y; Suzuki M
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):828-39. PubMed ID: 11697329
[TBL] [Abstract][Full Text] [Related]
3. Responses of total and quiescent cell populations in solid tumors to boron and gadolinium neutron capture reaction using neutrons with two different energy spectra.
Masunaga S; Ono K; Sakurai Y; Suzuki M; Takagaki M; Kobayashi T; Kinashi Y; Akaboshi M
Jpn J Cancer Res; 1998 Jan; 89(1):81-8. PubMed ID: 9510480
[TBL] [Abstract][Full Text] [Related]
4. Alteration of sensitivity of intratumor quiescent and total cells to gamma-rays following thermal neutron irradiation with or without 10B-compound.
Masunaga S; Ono K; Suzuki M; Sakurai Y; Kobayashi T; Takagaki M; Kinashi Y; Akaboshi M
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):653-9. PubMed ID: 10701745
[TBL] [Abstract][Full Text] [Related]
5. Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia.
Masunaga S; Ono K; Suzuki M; Takagaki M; Sakurai Y; Kobayashi T; Akuta K; Akaboshi M; Kinashi Y; Abe M
Br J Radiol; 1997 Apr; 70(832):391-8. PubMed ID: 9166076
[TBL] [Abstract][Full Text] [Related]
6. Reoxygenation in quiescent and total intratumor cells following thermal neutron irradiation with or without (10)B-compound-compared with that after gamma-ray irradiation.
Masunaga S; Ono K; Suzuki M; Sakurai Y; Kobayashi T; Takagaki M; Kinashi Y; Akaboshi M
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):391-8. PubMed ID: 10760435
[TBL] [Abstract][Full Text] [Related]
7. Repair of potentially lethal damage by total and quiescent cells in solid tumors following a neutron capture reaction.
Masunaga S; Ono K; Suzuki M; Sakurai Y; Takagaki M; Kobayashi T; Kinashi Y; Akaboshi M
J Cancer Res Clin Oncol; 1999 Nov; 125(11):609-14. PubMed ID: 10541967
[TBL] [Abstract][Full Text] [Related]
8. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
9. Impact of the p53 status of the tumor cells on the effect of reactor neutron beam irradiation, with emphasis on the response of intratumor quiescent cells.
Masunaga S; Ono K; Takahashi A; Sakurai Y; Ohnishi K; Kobayashi T; Kinashi Y; Takagaki M; Ohnishi T
Jpn J Cancer Res; 2002 Dec; 93(12):1366-77. PubMed ID: 12495477
[TBL] [Abstract][Full Text] [Related]
10. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.
Masunaga SI; Ono K; Kirihata M; Takagaki M; Sakurai Y; Kinashi Y; Kobayashi T; Nagasawa H; Uto Y; Hori H
Jpn J Cancer Res; 2001 Sep; 92(9):996-1007. PubMed ID: 11572769
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
Masunaga S; Nagasawa H; Gotoh K; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Radiat Med; 2006 Feb; 24(2):98-107. PubMed ID: 16715670
[TBL] [Abstract][Full Text] [Related]
13. The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
Masunaga S; Nagasawa H; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Int J Hyperthermia; 2006 Jun; 22(4):287-99. PubMed ID: 16754350
[TBL] [Abstract][Full Text] [Related]
14. Applicability of combination with tirapazamine in boron neutron capture therapy.
Masunaga S; Ono K; Sakurai Y; Hori H; Kobayashi T; Takagaki M; Suzuki M; Kinashi Y; Akaboshi M
Jpn J Cancer Res; 1998 Jul; 89(7):768-74. PubMed ID: 9738984
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
[TBL] [Abstract][Full Text] [Related]
16. Radiobiologic significance of apoptosis and micronucleation in quiescent cells within solid tumors following gamma-ray irradiation.
Masunaga S; Ono K; Suzuki M; Kinashi Y; Takagaki M
Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1361-8. PubMed ID: 11286844
[TBL] [Abstract][Full Text] [Related]
17. Potential of alpha-amino alcohol p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, regarding its enantiomers.
Masunaga S; Ono K; Kirihata M; Takagaki M; Sakurai Y; Kinashi Y; Kobayashi T; Suzuki M; Nagata K; Nagasawa H; Uto Y; Hori H
J Cancer Res Clin Oncol; 2003 Jan; 129(1):21-8. PubMed ID: 12618897
[TBL] [Abstract][Full Text] [Related]
18. The impact of TP53 status of tumor cells including the type and the concentration of administered 10B delivery agents on compound biological effectiveness in boron neutron capture therapy.
Masunaga SI; Sanada Y; Takata T; Tanaka H; Sakurai Y; Suzuki M; Kirihata M; Ono K
J Radiat Res; 2023 Mar; 64(2):399-411. PubMed ID: 36763853
[TBL] [Abstract][Full Text] [Related]
19. Augmentation in chemosensitivity of intratumor quiescent cells by combined treatment with nicotinamide and mild hyperthermia.
Masunaga S; Ono K; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Takagaki M
Jpn J Cancer Res; 1997 Aug; 88(8):770-7. PubMed ID: 9330609
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
Masunaga S; Ono K; Nishimura Y; Kanamori S; Saga T; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y; Hori H
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):799-807. PubMed ID: 10837967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
